Clinical Trials Logo

Radiomics clinical trials

View clinical trials related to Radiomics.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06452550 Recruiting - Radiomics Clinical Trials

Neurophenotype Predicts CD Disease Progression

Start date: May 1, 2021
Phase:
Study type: Observational

The goal of this observational study is aimed to develop a novel multimodal neuroimaging-based model to characterize the neurophenotype of Crohn's Disease patients and assess its ability for predicting disease progression, using multiomics data to interpret the model. Participants will be followed-up of at least six months for patients without disease progression to assess the relationship between neurophenotype and intestinal outcomes.

NCT ID: NCT05736991 Recruiting - Lung Adenocarcinoma Clinical Trials

Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

Start date: November 1, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting the grade 3 tumors based on the novel grading system in clinical stage stage I lung adenocarcinoma based on a multicenter prospective cohort.

NCT ID: NCT05174208 Recruiting - Crohn Disease Clinical Trials

Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease

Start date: January 1, 2022
Phase:
Study type: Observational

Crohn's disease (CD), a type of inflammatory bowel disease (IBD), is a chronic intestinal recurrent inflammatory disease involving the entire digestive tract. Most CD patients require surgery for complications, including stenosis, perforation, and severe intestinal bleeding. Predicting early-onset surgery risk is of great importance to assist launching of therapeutic strategies. We aim to establish a digital prognostic model and nomogram using radiomics, which will help clinical practice.

NCT ID: NCT04792437 Recruiting - Glioma Clinical Trials

Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data

Start date: March 10, 2021
Phase:
Study type: Observational

This project intends to use multiple types of biological samples from glioma patients and mouse intracranial tumor models as research objects, and comprehensively apply a series of omics sequencing technologies and molecular biology technologies to jointly define the following research objectives :

NCT ID: NCT04553601 Recruiting - NSCLC Clinical Trials

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

To assess the potential usefulness of radiogenomics for tumor driving genes heterogeneity in non-small cell lung cancer.

NCT ID: NCT04483804 Recruiting - Breast Cancer Clinical Trials

Application of Radiomics in Breast Cancer

Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

NCT ID: NCT04004559 Recruiting - Clinical trials for Invasive Breast Cancer

MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)

RBC-02
Start date: May 28, 2019
Phase:
Study type: Observational

This study is aimed to illustrate whether Radiomics combining multiparametric MRI before and after neoadjuvant chemotherapy (NACT) with clinical data is a good way to predict axillary lymph node metastasis and prognosis in invasive-breast-cancer.

NCT ID: NCT04003558 Recruiting - Clinical trials for Breast Neoplasm Female

Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)

Start date: May 28, 2019
Phase:
Study type: Observational

This bi-directional, multicentre study aims to assess multiparametric MRI Radiomics-based prediction model for identifying metastasis lymph nodes and prognostic prediction in breast cancer.

NCT ID: NCT03871140 Recruiting - Ablation Clinical Trials

Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis

Start date: January 1, 2017
Phase:
Study type: Observational

Ultrasound (US) as first-line imaging technology in detecting focal liver lesions,also plays a crucial role in evaluating image and guiding ablation which is the main treatment for liver lesions. However, the effect of US in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, low resolution for lesion feature,large error from thermal field evaluation during the process of ablation and so on. Therefore, it is of great significance to construct an intelligent US analysis system depending on the digital information technology. Basing on these problems,the following research will be involved in our project: 1) US database of liver lesions with seamless connection to Picture Archiving and Communication Systems (PACS) will be developed, with the aim to provide standard data for intelligent US analysis. 2) Deep learning model for accurate segmentation, detection and classification of liver lesions on US images will be studied. Then automatic extraction, selection and analysis of liver lesion ultrasound features and the intelligent US diagnosis for liver lesions will be realized. 3) Proposing a clustering model with deep image features, and depicting the similarity measurement of liver cancer, which can be furthered used to link the liver cancer feature to optimal ablation parameters. The intelligent decision-making system for quantifying thermal ablation will be established. 4) Regression algorithm and Generative Adversarial Nets will be developed to extract the image features of liver cancer which will predict risk factors after US-guided thermal ablation.Based on the above researches, it is of great value to establish an intelligent focal liver lesion US diagnosis system involving intelligent diagnosis,personalized ablation strategy and accurate prognosis evaluation, improving the level of accurate diagnosis and treatment of liver lesions.

NCT ID: NCT03592004 Recruiting - Breast Cancer Clinical Trials

Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

Start date: July 18, 2018
Phase:
Study type: Observational

This is a single-arm, multicentre study that aims to assess whether Radiomics combining multiparametric MRI and clinical data could be a good predictor of the responses to neoadjuvant chemotherapy in Breast Cancer.